ANEB_OUT_1 [2025-03-19 15:46:53 -0400] 2183 Bytes | 580 tokens | Cum: 580 tkns (7.25% of 8k)
==========================================================================

We are in the 'Lightning Round' baby! It's 03:46:52 PM on Wednesday March 19, 2025 ET (UTC-0400), and I'm firing up the spotlight on Anebulo Pharmaceuticals (ANEB), moving from 1.77 to 2.04. Is this a can’t-miss rocket or a one-hit wonder? Let’s dissect the numbers!

Here's the first list of news for Anebulo Pharmaceuticals:

C1 - Feb-14-25 04:05PM - Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates
C2 - Dec-24-24 09:25AM - Anebulo Pharmaceuticals collaborates with FDA to advance selonabant
C3 - Dec-23-24 09:15AM - Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise
C4 - Nov-13-24 04:05PM - Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates
C5 - Sep-25-24 04:05PM - Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates
C6 - Jul-22-24 07:00AM - Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects
C7 - Jul-01-24 08:00AM - Lifecore Biomedical Announces Cooperation Agreement with 22NW
C8 - May-15-24 09:55PM - ANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024

ONLY 3 RULES for AI:
==============
1) This is a document retrieval system. You are the analyst-investigator.
2) You can request items from any list to get more details about Anebulo Pharmaceuticals (ANEB)
3) AFTER requesting and reading News and SEC filings you'll get tokens to write a summary, set a score and high price target, and finally take an exit quiz.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.

Thank you for your analysis of Anebulo Pharmaceuticals.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!

Please request a document, read, summarize and score. Say something like "C1".

ANEB_OUT_3 [2025-03-19 15:47:00 -0400] 448 Bytes | 125 tokens | Cum: 707 tkns (8.84% of 8k)
==========================================================================

Showing C3 (chunk 1 of 1): C3:
**Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise**
Date: Dec-23-24 09:15AM
Source: (Business Wire)
URL: https://www.businesswire.com/news/home/20241223198725/en/

Error fetching article: 403 Client Error: Forbidden for url: https://www.businesswire.com/news/home/20241223198725/en/

-- More? (MOR) or Next section? (NEX)

ANEB_OUT_5 [2025-03-19 15:47:01 -0400] 702 Bytes | 209 tokens | Cum: 1045 tkns (13.06% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-13T17:20:27Z - 12 Health Care Stocks Moving In Thursday's Intraday Session - Aveanna Healthcare Hldgs (NASDAQ:AVAH)...
A2 - 2025-02-21T13:02:59Z - Anebulo Pharmaceuticals files to sell 15.15M shares of common stock for holders...
A3 - 2025-02-19T13:11:13Z - Pre-market Movers: SINT, CYCU, OSRH, RSLS, NIVF....

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

ANEB_OUT_7 [2025-03-19 15:47:03 -0400] 967 Bytes | 300 tokens | Cum: 1347 tkns (16.84% of 8k)
==========================================================================

Showing A1 (chunk 1 of 4): A1:
**12 Health Care Stocks Moving In Thursday's Intraday Session - Aveanna Healthcare Hldgs (NASDAQ:AVAH), Anebulo Pharmaceuticals (NASDAQ:ANEB)**Date: 2025-03-13Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/03/44310216/12-health-care-stocks-moving-in-thursdays-intraday-sessionGainers Regencell Bioscience RGC stock moved upwards by 137.3% to $9.96 during Thursday's regular session. The market value of their outstanding shares is at $129.6 million. Aveanna Healthcare Hldgs AVAH shares rose 39.3% to $5.21. The company's market cap stands at $1.0 billion. As per the news, the Q4 earnings report came out today. MeiraGTx Hldgs MGTX shares rose 23.55% to $7.92. The company's market cap stands at $618.9 million. The company's, Q4 earnings came out today. Sharps Technology STSS shares increased by 20.18% to $0.36. The co

-- More? (MOR) or Next section? (NEX)

ANEB_OUT_9 [2025-03-19 15:47:04 -0400] 967 Bytes | 277 tokens | Cum: 1626 tkns (20.32% of 8k)
==========================================================================

Showing A1 (chunk 2 of 4): mpany's market cap stands at $1.9 million. Anebulo Pharmaceuticals ANEB shares increased by 18.84% to $1.64. The market value of their outstanding shares is at $67.3 million. Pharming PHAR shares increased by 18.56% to $9.18. The company's market cap stands at $622.5 million. As per the news, the Q4 earnings report came out today. Losers Dogwood Therapeutics DWTX shares declined by 28.7% to $7.63 during Thursday's regular session. The market value of their outstanding shares is at $10.1 million. CERo Therapeutics Hldgs CERO stock fell 25.74% to $1.01. The market value of their outstanding shares is at $3.0 million. TransCode Therapeutics RNAZ shares decreased by 23.34% to $0.78. Biote BTMD stock decreased by 22.06% to $3.2. The market value of their outstanding shares is at $99.4 million. As per the news, the Q4 earnings report came out yesterday. Hepion Pharmaceuticals HEPA shares decli

-- More? (MOR) or Next section? (NEX)

ANEB_OUT_11 [2025-03-19 15:47:06 -0400] 900 Bytes | 293 tokens | Cum: 1922 tkns (24.02% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2023-10-19T13:40:10Z - Are Medical Stocks Lagging Anebulo Pharmaceuticals (ANEB) This Year?
B2 - 2023-10-17T17:42:48Z - Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B3 - 2023-10-03T13:40:08Z - Are Medical Stocks Lagging Exact Sciences (EXAS) This Year?
B4 - 2023-09-18T17:13:10Z - Substance Use Disorder Focused Anebulo Could Be Attractive Acquisition Target, Analyst Says
B5 - 2023-09-18T15:00:36Z - Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023
B6 - 2023-08-22T13:37:00Z - Anebulo (ANEB) Gains on Positive FDA Response for ANEB-001

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

ANEB_OUT_13 [2025-03-19 15:47:10 -0400] 421 Bytes | 127 tokens | Cum: 2051 tkns (25.64% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Are Medical Stocks Lagging Anebulo Pharmaceuticals (ANEB) This Year?**Date: Unknown DateSource: Unknown SourceURL: https://www.zacks.com/stock/news/2168764/are-medical-stocks-lagging-anebulo-pharmaceuticals-aneb-this-yearHere is how Anebulo Pharmaceuticals, Inc. (ANEB) and Conmed (CNMD) have performed compared to their sector so far this year.

-- More? (MOR) or Next section? (NEX)

ANEB_OUT_15 [2025-03-19 15:47:11 -0400] 1133 Bytes | 325 tokens | Cum: 2446 tkns (30.58% of 8k)
==========================================================================

This is our list of SEC filings.
Read it just by asking.
Don't miss breaking filings!

S1 - 2025-02-24 8-K Item 1.01 Entry Into a Material Definitive Agrmt

As previously disclosed, on December 22, 2024, Anebulo Pharmaceuticals, Inc., a Delaware corporation (the Company), entered into a securities purchase agreement (the Purchase Agrmt) with 22NW Fund, LP (22NW), as well as o...

S2 - 2025-02-14 10-Q PART I. FIN INFO

Anebulo Pharmaceuticals, Inc.

Condensed Balance Sheets

(unaudited)

December 31, 2024 June 30, 2024 Assets Curr assets: Cash and cash equiv $ 14,998,467 $ 3,094,200 Grant receivable 30,756 - Prepaid expenses 366,266 413,790 Total cu...

S3 - 2025-02-14 8-K Item 2.02 Results of Oper and Fin Cond.

On February 14, 2025, Anebulo Pharmaceuticals, Inc., a Delaware corporation (the Company), issued a press release announcing its financial results for the quarter ended December 31, 2024 and providing a business update. A...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing - but what fun is that?
Response limited to 3 chars.

ANEB_OUT_17 [2025-03-19 15:47:13 -0400] 967 Bytes | 244 tokens | Cum: 2692 tkns (33.65% of 8k)
==========================================================================

Showing S1 (chunk 1 of 3): S1:
Item 1.01 Entry Into a Material Definitive Agreement

As previously disclosed, on December 22, 2024, Anebulo Pharmaceuticals, Inc., a Delaware corporation (the Company), entered into a securities purchase agreement (the Purchase Agreement) with 22NW Fund, LP (22NW), as well as other institutional accredited investors (the Investors), pursuant to which the Company issued to the Investors, in a private placement priced at-the-market (the Private Placement), an aggregate of 15,151,514 shares of Common Stock, of which 10,101,010 of such shares (the Shares) were issued to 22NW, a greater than 5% stockholder of the Company that is controlled by Aron English, a director of the Company. The Private Placement closed on December 23, 2024.

On February 24, 2025 , the Company entered into a lock-up agreement (the Lock-Up Agreement) with 22NW pursuant to which 22NW agreed not to vote, sell, tra

-- More? (MOR) or Next section? (NEX)

ANEB_OUT_19 [2025-03-19 15:47:15 -0400] 967 Bytes | 209 tokens | Cum: 2903 tkns (36.29% of 8k)
==========================================================================

Showing S1 (chunk 2 of 3): nsfer, pledge or otherwise dispose of the Shares that were issued to it in the Private Placement. Pursuant to the Lock-Up Agreement, the Company agreed to hold a stockholder meeting no later than April 30, 2025 and to submit a proposal for the removal of the voting and transfer restrictions set forth in the Lock-Up Agreement at such stockholder meeting. The Lock-Up Agreement further provides that any failure of the Company to hold a stockholder meeting to remove the lock-up restrictions by April 30, 2025 or to have the restrictions on voting and transfer of the Shares removed after receiving stockholder approval would be deemed a breach of the Lock-Up Agreement and 22NW would have a right to have the Shares redeemed.

In conjunction with entering into the Lock-Up Agreement, the Company executed an irrevocable letter (the Irrevocable Instruction Letter), which was acknowledged and agreed

-- More? (MOR) or Next section? (NEX)

ANEB_OUT_21 [2025-03-19 15:47:28 -0400] 3249 Bytes | 792 tokens | Cum: 3698 tkns (46.23% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+--------------------+--------------------+----------------------+------------------------+----------------------+-----------------------+
| Prev Close: 1.77 | RSI (14): 75.17 | Perf Quarter: 55.17% | Insider Trans: 154.12% | Sales Q/Q: - | ROE: -71.49% |
+--------------------+--------------------+----------------------+------------------------+----------------------+-----------------------+
| Target Price: 8.00 | ATR (14): 0.24 | Index: - | Option/Short: No / Yes | Sales past 5Y: 0.00% | ROI: -51.24% |
+--------------------+--------------------+----------------------+------------------------+----------------------+-----------------------+
| Price: 2.17 | SMA20: 63.60% | Market Cap: 89.25M | Short Float: 0.26% | Income: -7.67M | Sales Surprise: - |
+--------------------+--------------------+----------------------+------------------------+----------------------+-----------------------+
| Change: 22.73% | SMA50: 49.16% | Shs Outstand: 41.08M | Short Ratio: 1.56 | Employees: 3 | EPS Surprise: -12.50% |
+--------------------+--------------------+----------------------+------------------------+----------------------+-----------------------+
| Volume: 59,689 | SMA200: 19.66% | Shs Float: 24.43M | Short Interest: 0.06M | Debt/Eq: 0.00 | P/E: - |
+--------------------+--------------------+----------------------+------------------------+----------------------+-----------------------+
| Avg Volume: 40.09K | Perf Week: 57.42% | Inst Own: 54.94% | Beta: -1.39 | Sales Y/Y TTM: - | Earnings: Feb 14 AMC |
+--------------------+--------------------+----------------------+------------------------+----------------------+-----------------------+
| Rel Volume: 1.61 | Perf Month: 48.79% | Insider Own: 40.54% | Sales: 0.00M | Profit Margin: - | |
+--------------------+--------------------+----------------------+------------------------+----------------------+-----------------------+

The next section covers any insider trading.
If this section is blank, it's because there've been no recent filings.

Inside Trans: Anebulo Pharmaceuticals, Inc. (ANEB) by English Aron R. (Unknown Title) on 2024-12-23
- Common Stock: 10101010 shares at $0.99 (I)

Now we've reached the end of the analysis.
You are now allotted tokens to make a final analysis summary.
Please don't use tokens to explain why you didn't have enough information.
Save that for the survey that comes last.

Finish the summary with two scores: MARKET_SCORE[] and PRICE_TARGET[]

If you think there's a 90% likelihood of an upward moves, say: MARKET_SCORE[90]
If you think the high today will be 50% higher, add to the price. Eg., If the price is $5.00, add 50%: PRICE_TARGET[$7.50]
PRICE_TARGET is the highest it is expected to rise today, so it cannot be less than the current price.

After you have completed that, please provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-10 words headline for news story from first summary paragraph]

ANEB_OUT_23 [2025-03-19 15:47:30 -0400] 561 Bytes | 131 tokens | Cum: 4082 tkns (51.02% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings & insider data
-> X3 <- Broader sector & market news
-> X4 <- General market sentiment & AI confidence levels
-> X5 <- AI's past analysis on similar companies
-> X6 <- More financial metrics
-> X7 <- AI's past analysis on this exact company
-> X8 <- Something altogether different (explain...)

ANEB_IN_25 [2025-03-19 15:47:30 -0400] 126 Bytes | 29 tokens | Cum: 4121 tkns (51.51% of 8k)
==========================================================================

====================================
[2025-03-19 12:47:30] # Analysis Completed
Elapsed Time: 38.71 seconds